Dupilumab effect on pruritus neuro-mechanisms in patients with atopic dermatitis

Trial Identifier: LPS16763
Sponsor: Sanofi
Collaborator:
Regeneron Pharmaceuticals
Start Date: April 2021
Primary Completion Date: June 2022
Study Completion Date: August 2022
Condition: Eczema

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Germany Münster, Germany, 48149
United States, Florida Miami, Florida, United States, 33136
United States, New Jersey East Windsor, New Jersey, United States, 08520